FDA Warning physicians of drug injury caused by tamoxifen interaction with antidepressants
The Wall Street Journal (6/2, B8, Dooren) reports, “The Food and Drug Administration is planning to warn doctors about an interaction between the widely used breast-cancer drug tamoxifen and certain antidepressants after a study showed women on both drugs were more than twice as likely to see their cancer return.” The study, reported at the … Read more